NCT04938167View on ClinicalTrials.gov

Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension

NAActive, not recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Persistent Pulmonary Hypertension of the NewbornHypoxemic Respiratory Failure
Interventions
OTHER

95% - 99% SpO2 target

If the infant is randomized to the intervention arm, the oxygen saturation goal will be changed from the standard goal of 91% - 95% to the experimental goal of 95%-99%. The treating medical team will then adjust the oxygen and respiratory support to maintain these goals (SpO2 alarm levels will be set at 93% and 100%).

Trial Locations (1)

95817

University of California-Davis, Sacramento

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of California, Davis

OTHER